Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Accumulated Expenses: 2022-2024

Historic Other Accumulated Expenses for Capricor Therapeutics (CAPR) over the last 3 years, with Dec 2024 value amounting to $435,712.

  • Capricor Therapeutics' Other Accumulated Expenses rose 26121.55% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 26121.55%. This contributed to the annual value of $435,712 for FY2024, which is 4257.12% up from last year.
  • According to the latest figures from FY2024, Capricor Therapeutics' Other Accumulated Expenses is $435,712, which was up 4,257.12% from $10,000 recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Other Accumulated Expenses registered a high of $435,712 during FY2024, and its lowest value of $10,000 during FY2023.
  • Over the past 3 years, Capricor Therapeutics' median Other Accumulated Expenses value was $89,234 (recorded in 2022), while the average stood at $178,315.
  • As far as peak fluctuations go, Capricor Therapeutics' Other Accumulated Expenses slumped by 88.79% in 2023, and later surged by 4,257.12% in 2024.
  • Capricor Therapeutics' Other Accumulated Expenses (Yearly) stood at $89,234 in 2022, then tumbled by 88.79% to $10,000 in 2023, then spiked by 4,257.12% to $435,712 in 2024.